333 related articles for article (PubMed ID: 32244740)
1. Possible Role of Mitochondrial DNA Mutations in Chronification of Inflammation: Focus on Atherosclerosis.
Orekhov AN; Nikiforov NN; Ivanova EA; Sobenin IA
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32244740
[TBL] [Abstract][Full Text] [Related]
2. Do Mitochondrial DNA Mutations Play a Key Role in the Chronification of Sterile Inflammation? Special Focus on Atherosclerosis.
Orekhov AN; Gerasimova EV; Sukhorukov VN; Poznyak AV; Nikiforov NG
Curr Pharm Des; 2021; 27(2):276-292. PubMed ID: 33045961
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations.
Orekhov AN; Ivanova EA; Markin AM; Nikiforov NG; Sobenin IA
Curr Atheroscler Rep; 2020 Aug; 22(10):54. PubMed ID: 32772280
[TBL] [Abstract][Full Text] [Related]
4. Defective Mitophagy Impairs Response to Inflammatory Activation of Macrophage-Like Cells.
Orekhov AN; Zhuravlev AD; Vinokurov AY; Nikiforov NG; Omelchenko AV; Sukhorukov VN; Sinyov VV; Sobenin IA
Curr Med Chem; 2024 Mar; ():. PubMed ID: 38441018
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
[TBL] [Abstract][Full Text] [Related]
6. The Role of Mitochondrial Mutations in Chronification of Inflammation: Hypothesis and Overview of Own Data.
Orekhov AN; Nikiforov NG; Omelchenko AV; Sinyov VV; Sobenin IA; Vinokurov AY; Orekhova VA
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013333
[TBL] [Abstract][Full Text] [Related]
7. Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations.
Markin AM; Sobenin IA; Grechko AV; Zhang D; Orekhov AN
Front Pharmacol; 2020; 11():642. PubMed ID: 32528276
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy.
Sukhorukov VN; Khotina VA; Kalmykov VA; Zhuravlev AD; Sinyov VV; Popov DY; Vinokurov AY; Sobenin IA; Orekhov AN
J Lipid Atheroscler; 2024 May; 13(2):166-183. PubMed ID: 38826184
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies.
Shemiakova T; Ivanova E; Wu WK; Kirichenko TV; Starodubova AV; Orekhov AN
Front Cardiovasc Med; 2021; 8():660473. PubMed ID: 34017868
[TBL] [Abstract][Full Text] [Related]
11. From Mitochondria to Atherosclerosis: The Inflammation Path.
Suárez-Rivero JM; Pastor-Maldonado CJ; Povea-Cabello S; Álvarez-Córdoba M; Villalón-García I; Talaverón-Rey M; Suárez-Carrillo A; Munuera-Cabeza M; Sánchez-Alcázar JA
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33807807
[TBL] [Abstract][Full Text] [Related]
12. The Role of Mitophagy in Innate Immunity.
Gkikas I; Palikaras K; Tavernarakis N
Front Immunol; 2018; 9():1283. PubMed ID: 29951054
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory reactions in the pathogenesis of atherosclerosis.
Fan J; Watanabe T
J Atheroscler Thromb; 2003; 10(2):63-71. PubMed ID: 12740479
[TBL] [Abstract][Full Text] [Related]
14. Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids.
Swiader A; Nahapetyan H; Faccini J; D'Angelo R; Mucher E; Elbaz M; Boya P; Vindis C
Oncotarget; 2016 May; 7(20):28821-35. PubMed ID: 27119505
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Aging: Focus on Mitochondrial DNA Damage in Atherosclerosis - A Mini-Review.
Sobenin IA; Zhelankin AV; Sinyov VV; Bobryshev YV; Orekhov AN
Gerontology; 2015; 61(4):343-9. PubMed ID: 25531813
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and immune system contribution to the etiology of atherosclerosis: mechanisms and methods of assessment.
Salisbury D; Bronas U
Nurs Res; 2014; 63(5):375-85. PubMed ID: 25171563
[TBL] [Abstract][Full Text] [Related]
17. The immunology of atherosclerosis.
Gisterå A; Hansson GK
Nat Rev Nephrol; 2017 Jun; 13(6):368-380. PubMed ID: 28392564
[TBL] [Abstract][Full Text] [Related]
18. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis.
Gibson FC; Ukai T; Genco CA
Front Biosci; 2008 Jan; 13():2041-59. PubMed ID: 17981690
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases.
Dela Cruz CS; Kang MJ
Mitochondrion; 2018 Jul; 41():37-44. PubMed ID: 29221810
[TBL] [Abstract][Full Text] [Related]
20. Complement and atherosclerosis-united to the point of no return?
Torzewski M; Bhakdi S
Clin Biochem; 2013 Jan; 46(1-2):20-5. PubMed ID: 23010447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
